Chrysler
Summary
NHTSA campaign 23V577: Chrysler recalled for a safety defect. A rearview image that does not display while in reverse decreases the driver's visibility of the rear view, increasing t
Details
Source
nhtsa
External ID
23V577
Action Date
2023-08-14
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee, 2021-2023 Jeep Grand Cherokee L, and 2022-2024 Jeep Wagoneer and Grand Wagoneer vehicles. The Central Vision Park Assist module (CVPAM) software may prevent the rearview image from displaying when the vehicle is placed in reverse. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard number 111, "Rear Visibility."
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle